NEW YORK (360Dx) – The US Food and Drug Administration has cleared Accelerate Diagnostics' test kit and instrument platform for identifying organisms that cause bloodstream infections, the company said late Thursday.

The kit also provides information about antibiotic sensitivity, and with the clearance Accelerate can market the test and platform in the US.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.